| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligase activity, forming carbon-oxygen bonds | 1.49e-04 | 42 | 49 | 3 | GO:0016875 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA ligase activity | 1.49e-04 | 42 | 49 | 3 | GO:0004812 | |
| GeneOntologyCellularComponent | immunological synapse | 2.20e-04 | 49 | 50 | 3 | GO:0001772 | |
| GeneOntologyCellularComponent | myofibril | 4.80e-04 | 273 | 50 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.31e-04 | 290 | 50 | 5 | GO:0043292 | |
| Domain | HGTP_anticodon | 2.30e-04 | 9 | 48 | 2 | PF03129 | |
| Domain | aa-tRNA-synt_IIb | 3.51e-04 | 11 | 48 | 2 | IPR002314 | |
| Domain | tRNA-synt_2b | 3.51e-04 | 11 | 48 | 2 | PF00587 | |
| Domain | - | 3.51e-04 | 11 | 48 | 2 | 3.40.50.800 | |
| Domain | Anticodon-bd | 5.77e-04 | 14 | 48 | 2 | IPR004154 | |
| Domain | aa-tRNA-synth_I_CS | 9.64e-04 | 18 | 48 | 2 | IPR001412 | |
| Domain | aa-tRNA-synth_II | 9.64e-04 | 18 | 48 | 2 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 9.64e-04 | 18 | 48 | 2 | PS50862 | |
| Domain | AA_TRNA_LIGASE_I | 1.08e-03 | 19 | 48 | 2 | PS00178 | |
| Domain | GST_C | 2.02e-03 | 26 | 48 | 2 | IPR004046 | |
| Domain | GST_C | 2.02e-03 | 26 | 48 | 2 | PF00043 | |
| Domain | HECT | 2.18e-03 | 27 | 48 | 2 | PF00632 | |
| Domain | HECTc | 2.18e-03 | 27 | 48 | 2 | SM00119 | |
| Domain | HECT_dom | 2.18e-03 | 27 | 48 | 2 | IPR000569 | |
| Domain | HECT | 2.18e-03 | 27 | 48 | 2 | PS50237 | |
| Domain | Thioredoxin | 2.87e-03 | 31 | 48 | 2 | PF00085 | |
| Domain | EF-hand_8 | 3.44e-03 | 34 | 48 | 2 | PF13833 | |
| Domain | Pkinase_C | 4.07e-03 | 37 | 48 | 2 | IPR017892 | |
| Domain | Glutathione-S-Trfase_C-like | 4.51e-03 | 39 | 48 | 2 | IPR010987 | |
| Domain | - | 4.51e-03 | 39 | 48 | 2 | 1.20.1050.10 | |
| Domain | Thioredoxin_domain | 4.98e-03 | 41 | 48 | 2 | IPR013766 | |
| Domain | Pkinase_C | 5.22e-03 | 42 | 48 | 2 | PF00433 | |
| Domain | Rossmann-like_a/b/a_fold | 5.46e-03 | 43 | 48 | 2 | IPR014729 | |
| Domain | - | 5.46e-03 | 43 | 48 | 2 | 3.40.50.620 | |
| Pathway | WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS | 7.40e-06 | 13 | 43 | 3 | M39463 | |
| Pubmed | EPRS1 TARS3 XRN2 LDB1 ZNF473 HLA-DRA KIF1B MCF2L2 PKM LRP2 MAP3K10 TLN2 ZNFX1 HECTD1 VARS1 RYR3 | 1.66e-11 | 1285 | 50 | 16 | 35914814 | |
| Pubmed | 4.85e-06 | 23 | 50 | 3 | 11487543 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18792400 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 23760366 | ||
| Pubmed | CD4 raft association and signaling regulate molecular clustering at the immunological synapse site. | 1.21e-05 | 4 | 50 | 2 | 15128768 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 10535319 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 24312579 | ||
| Pubmed | 3.03e-05 | 6 | 50 | 2 | 36038948 | ||
| Pubmed | 3.14e-05 | 1139 | 50 | 9 | 36417873 | ||
| Pubmed | 3.41e-05 | 638 | 50 | 7 | 33239621 | ||
| Pubmed | 3.76e-05 | 130 | 50 | 4 | 12421765 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 23555860 | ||
| Pubmed | 5.64e-05 | 8 | 50 | 2 | 18246200 | ||
| Pubmed | Syntaxin 3 and Munc-18-2 in epithelial cells during kidney development. | 9.05e-05 | 10 | 50 | 2 | 10469351 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.14e-04 | 774 | 50 | 7 | 15302935 | |
| Pubmed | A Critical Role for Estrogen-Related Receptor Signaling in Cardiac Maturation. | 1.20e-04 | 66 | 50 | 3 | 32212902 | |
| Pubmed | 1.80e-04 | 1431 | 50 | 9 | 37142655 | ||
| Pubmed | MAP3Ks as central regulators of cell fate during development. | 2.10e-04 | 15 | 50 | 2 | 18855897 | |
| Pubmed | High-throughput RNAi screening reveals novel regulators of telomerase. | 2.40e-04 | 16 | 50 | 2 | 21531765 | |
| Pubmed | A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymes. | 2.81e-04 | 88 | 50 | 3 | 27182664 | |
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 32901292 | ||
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 12519789 | ||
| Pubmed | 3.73e-04 | 236 | 50 | 4 | 36339263 | ||
| Pubmed | 4.18e-04 | 21 | 50 | 2 | 12601173 | ||
| Pubmed | 4.99e-04 | 255 | 50 | 4 | 15324660 | ||
| Pubmed | 5.61e-04 | 469 | 50 | 5 | 37314180 | ||
| Pubmed | 6.07e-04 | 730 | 50 | 6 | 34857952 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 6.33e-04 | 736 | 50 | 6 | 29676528 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 6.44e-04 | 26 | 50 | 2 | 26949039 | |
| Pubmed | 7.29e-04 | 497 | 50 | 5 | 23414517 | ||
| Pubmed | Keeping the (kinase) party going: SLP-76 and ITK dance to the beat. | 7.48e-04 | 28 | 50 | 2 | 17652306 | |
| Pubmed | Global analysis of gene expression in the developing brain of Gtf2ird1 knockout mice. | 8.02e-04 | 29 | 50 | 2 | 21909369 | |
| Pubmed | 8.59e-04 | 30 | 50 | 2 | 35152003 | ||
| Pubmed | 9.17e-04 | 31 | 50 | 2 | 11048639 | ||
| Pubmed | 9.19e-04 | 132 | 50 | 3 | 22496890 | ||
| Pubmed | 1.19e-03 | 322 | 50 | 4 | 26514267 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 1.20e-03 | 1489 | 50 | 8 | 28611215 | |
| Pubmed | TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A. | 1.31e-03 | 37 | 50 | 2 | 29531219 | |
| Pubmed | 1.31e-03 | 37 | 50 | 2 | 19430480 | ||
| GeneFamily | Aminoacyl tRNA synthetases, Class I | 6.10e-04 | 19 | 35 | 2 | 131 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 9.78e-04 | 24 | 35 | 2 | 654 | |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 1.61e-05 | 166 | 50 | 5 | M9015 | |
| Coexpression | GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN | 3.76e-05 | 198 | 50 | 5 | M5670 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN | 3.85e-05 | 199 | 50 | 5 | M4575 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.90e-05 | 157 | 50 | 4 | ec185dbeabb67fd9ca85f71cab88463b60f9b1c1 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.97e-05 | 158 | 50 | 4 | 0c27c475289c70b17b6a66fc71f628511c5f0ae1 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 3.44e-05 | 164 | 50 | 4 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-05 | 164 | 50 | 4 | 2c48c6e4eeee845f0563982d0bfa2a176ca5ef61 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 167 | 50 | 4 | b5d15773be32cd277125fd3b4056a8fefaefa5ec | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 3.96e-05 | 170 | 50 | 4 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.05e-05 | 171 | 50 | 4 | 5885e69e997cc2f6a27afebfe57001ca0ac062a6 | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 4.14e-05 | 172 | 50 | 4 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 178 | 50 | 4 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.05e-05 | 181 | 50 | 4 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 5.27e-05 | 183 | 50 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.61e-05 | 186 | 50 | 4 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.73e-05 | 187 | 50 | 4 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 188 | 50 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.35e-05 | 192 | 50 | 4 | 758ca0dacf313787effda36e6d1adb809e5b3a4e | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 6.35e-05 | 192 | 50 | 4 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.48e-05 | 193 | 50 | 4 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.48e-05 | 193 | 50 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.48e-05 | 193 | 50 | 4 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 194 | 50 | 4 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.74e-05 | 195 | 50 | 4 | fbedb9978ded857fd35c2a8664f7579f42edaa36 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.74e-05 | 195 | 50 | 4 | f1f48e2e57b2282572959b152aad4bee05143f03 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.88e-05 | 196 | 50 | 4 | e08f90f7a923c2846cac859519b8dc7c0ac7cd03 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.01e-05 | 197 | 50 | 4 | 61f909737c5f630beffdd326c6844215643dbdde | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.15e-05 | 198 | 50 | 4 | 2e6630eab77b12a6059682ab5ba465f38e469102 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 200 | 50 | 4 | 9156f8fd61a833891d2f7b7fadd693b81b1e2d5a | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.44e-05 | 200 | 50 | 4 | 566fe2e78e6f35399ec6aad5964f6d4d8ade82c6 | |
| ToppCell | mild-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.44e-05 | 200 | 50 | 4 | ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.37e-04 | 132 | 50 | 3 | dbc0a332fd8f63ebdcf9716e45d7f46f26509349 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 4.77e-04 | 136 | 50 | 3 | f024015bf60e64b8657e410e24995a1edec85196 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.64e-04 | 144 | 50 | 3 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.87e-04 | 146 | 50 | 3 | f7349d63bb47f1f22ced8ff514edc1c11bc782e7 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.87e-04 | 146 | 50 | 3 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-04 | 148 | 50 | 3 | 1186ee0d15244fee74c1d09df3967c1b69f8ddce | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-04 | 148 | 50 | 3 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.22e-04 | 149 | 50 | 3 | f18bddc84b064f3d57a1281d5172c404d87f25da | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-04 | 151 | 50 | 3 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma|TCGA-Uterus / Sample_Type by Project: Shred V9 | 6.47e-04 | 151 | 50 | 3 | 2810bfa01bd3016aeba29735eb4a9284792e8aac | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.85e-04 | 154 | 50 | 3 | 89a60a79d07466d7ad05888d10a72d3b1ab384af | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.85e-04 | 154 | 50 | 3 | f1fea1a87e977221fa125b62287368be9af4987d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.85e-04 | 154 | 50 | 3 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 6.85e-04 | 154 | 50 | 3 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.85e-04 | 154 | 50 | 3 | b5604c0b0b9b283352a3f612f40883b9123475d1 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Solid_Tissue_Normal-Connective_tissue_normal-Connective_tissue_normal-1|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 6.85e-04 | 154 | 50 | 3 | 160b170a3ade8b246843c9854af332475c047ba0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 155 | 50 | 3 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 155 | 50 | 3 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-04 | 155 | 50 | 3 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 7.11e-04 | 156 | 50 | 3 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 7.11e-04 | 156 | 50 | 3 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.24e-04 | 157 | 50 | 3 | 432b8719a8afd289cf48068e12c26a349d753fcc | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.38e-04 | 158 | 50 | 3 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 7.65e-04 | 160 | 50 | 3 | 5744cd30709f38e84f7ec8893dc19d7a288b465a | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-04 | 161 | 50 | 3 | 52556b89808e551540f33a13f57417a6696c2438 | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 7.79e-04 | 161 | 50 | 3 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-04 | 161 | 50 | 3 | 54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-04 | 161 | 50 | 3 | 242891be849a4398fe8bea44875ae1ba57950944 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 8.22e-04 | 164 | 50 | 3 | 746833f74095c0f25ce76baf1069f1848c231933 | |
| ToppCell | Influenza_Severe-cDC|World / Disease group and Cell class | 8.22e-04 | 164 | 50 | 3 | c984228f73b9aa1aaf948541f64f41ed874770cd | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.36e-04 | 165 | 50 | 3 | 60b500eb2c10cccf309b8fb28a9119da22d6889c | |
| ToppCell | tumor_Lung-B_lymphocytes-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 8.36e-04 | 165 | 50 | 3 | 3d010a66abac3961cc99f20b1459cf0eb0f7510d | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.36e-04 | 165 | 50 | 3 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.36e-04 | 165 | 50 | 3 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.36e-04 | 165 | 50 | 3 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-04 | 166 | 50 | 3 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.51e-04 | 166 | 50 | 3 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Mast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.51e-04 | 166 | 50 | 3 | 004ab6a1425d812c7ce572205875fd702d4a9659 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-04 | 167 | 50 | 3 | 0aa1973141a2437df24c9857cd50ff3dfc7673c0 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.81e-04 | 168 | 50 | 3 | eba865465feb0f42055bb8f98946050eeb03d177 | |
| ToppCell | 367C-Lymphocytic-B_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.81e-04 | 168 | 50 | 3 | 1943ae24ff90218b8c2c10b4102b5007ae35fc85 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.81e-04 | 168 | 50 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 367C-Lymphocytic-B_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.81e-04 | 168 | 50 | 3 | f4414d462d35abd00e3c1446302d7060f8a48d48 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-04 | 168 | 50 | 3 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.81e-04 | 168 | 50 | 3 | c34dd4a9c54d8e9c8f118e6a3816548890cb0746 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-04 | 169 | 50 | 3 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.96e-04 | 169 | 50 | 3 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-04 | 169 | 50 | 3 | dcf92121fb00e3b6498e2648363e90ac044ea396 | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.96e-04 | 169 | 50 | 3 | 6fe82db874eff0f86e5c0d1cc81322eb9d7874eb | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 8.96e-04 | 169 | 50 | 3 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.96e-04 | 169 | 50 | 3 | 1de3ae36d3b60e961bfd9f7bdc37867b82a0417f | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 170 | 50 | 3 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 170 | 50 | 3 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 170 | 50 | 3 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 170 | 50 | 3 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 9.12e-04 | 170 | 50 | 3 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 170 | 50 | 3 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.12e-04 | 170 | 50 | 3 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 9.12e-04 | 170 | 50 | 3 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.27e-04 | 171 | 50 | 3 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.27e-04 | 171 | 50 | 3 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.27e-04 | 171 | 50 | 3 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-04 | 172 | 50 | 3 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.43e-04 | 172 | 50 | 3 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-04 | 172 | 50 | 3 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.43e-04 | 172 | 50 | 3 | 62ed3b70fa1f6c84ea80ff00f60d2562be292e9d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.43e-04 | 172 | 50 | 3 | 2ab720a4c96073339a1f8b95ec7699682df98acf | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_atypical|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.59e-04 | 173 | 50 | 3 | f135cc9dcf34f33ced3210171ab40ae6d77cfae0 | |
| ToppCell | severe-B_memory|severe / disease stage, cell group and cell class | 9.59e-04 | 173 | 50 | 3 | 3a987ac53a0136cc4c70ce8b901a15fc00c795e1 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-04 | 173 | 50 | 3 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-04 | 173 | 50 | 3 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| Disease | microglial activation measurement | 1.31e-04 | 59 | 49 | 3 | EFO_0010940 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.76e-04 | 12 | 49 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | bullous pemphigoid | 1.46e-03 | 34 | 49 | 2 | EFO_0007187 | |
| Disease | total hip arthroplasty, osteoarthritis | 2.23e-03 | 42 | 49 | 2 | EFO_0009806, MONDO_0005178 | |
| Disease | Multiple Sclerosis | 2.56e-03 | 45 | 49 | 2 | C0026769 | |
| Disease | Multiple Sclerosis, Acute Fulminating | 2.56e-03 | 45 | 49 | 2 | C0751324 | |
| Disease | grip strength measurement | 2.71e-03 | 350 | 49 | 4 | EFO_0006941 | |
| Disease | Neuroblastoma | 2.78e-03 | 47 | 49 | 2 | C0027819 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ADVAISASEFMFEET | 296 | P28330 | |
| FDMTDAGIDFCFEAI | 256 | P28332 | |
| EFQEVFGMSIEEFDR | 581 | Q6H8Q1 | |
| EEMAGFEFQVIAEDS | 526 | Q9NPG4 | |
| MFAGDFAESFSARVE | 61 | Q0D2K2 | |
| VHSEMFVGSDEFDFF | 201 | Q6WBX8 | |
| EFDFFQIGMDTEITF | 211 | Q6WBX8 | |
| SAGFFSEMTEDELVV | 351 | Q96HD1 | |
| SDTKDMNEFETEGFF | 126 | Q04759 | |
| FASLNEMEEFAEAED | 606 | Q02779 | |
| DAFTTEFFEDDAMLT | 91 | Q86U70 | |
| MEDFDDEAFVDDAGS | 931 | O60333 | |
| EFSSMDTFEDCEGAE | 1011 | Q86YR7 | |
| LTFSVETDVFGAMEE | 706 | Q8IYU2 | |
| DIIDGFAMTSFVTFE | 86 | Q8WXX7 | |
| FSSSELGGDFEFMDD | 146 | Q86VI4 | |
| FGVEQDVDMVFASFI | 231 | P14618 | |
| FTETSAVFEDGTMFE | 306 | O60774 | |
| AVFEDGTMFEAIDSV | 311 | O60774 | |
| DELDVSNFAEEFTEM | 341 | O75582 | |
| IDFDAQDSTIFFSDM | 746 | P98164 | |
| MEVFREEEEDSFSGD | 231 | Q8N8V4 | |
| EMEQFFSTFGELTVE | 721 | Q8N264 | |
| DSEEMEIDGDPFSAF | 121 | Q9UDY4 | |
| DEEDDFDSFIAEMPA | 806 | Q05DH4 | |
| AIDTGAFEVNFMDDV | 381 | Q9ULT8 | |
| MDDDDFGGFEAAETF | 1 | Q7Z6B0 | |
| EFMFDFDGDEIFHVD | 46 | P01903 | |
| MEAVAKFDFTASGED | 1 | O75791 | |
| EAMEDFTGGVAEFFE | 226 | P20807 | |
| EFVGFDAKMAEESSS | 126 | Q13620 | |
| FAEVDEDGGTFMDVL | 911 | Q03701 | |
| TKEEANGDVFETFMF | 346 | Q13029 | |
| PSDTVEMFEGEEFFA | 656 | Q9HB75 | |
| EMFEGEEFFAAFERG | 661 | Q9HB75 | |
| DVMSEDGFFYLSFAE | 231 | Q96RQ9 | |
| MFTSEFDAEVDESES | 1011 | Q9Y6R4 | |
| VSSEFFEEGFMADVD | 716 | A2RTX5 | |
| VFDEFVDMDFGTGAV | 576 | P26640 | |
| FIEGADAETFSEGEM | 551 | P07814 | |
| SFFAPEEENEEDFQM | 926 | Q8IZX4 | |
| EFVDEGSTSMDLFEA | 1316 | Q149N8 | |
| IDNTAFMDEFFSEIE | 26 | Q13277 | |
| LFFSMVDYDEGTDVF | 126 | Q13454 | |
| DQCDFEEFVSFMTSG | 206 | Q8N427 | |
| SFNDEEEEEAMVFFV | 4451 | Q15413 | |
| FASDFEGIADMPSDF | 571 | Q9H0D6 | |
| SDDEFFDAREEMAEG | 31 | Q9BZ71 | |
| HMDEVTQIFFGFEDE | 1566 | Q9P2E3 | |
| FSDDFDEFLDAGIEM | 1276 | Q9Y4G6 | |
| EDGSGTVDFDEFLVM | 66 | P63316 | |
| MEDFFEEGFSQEIIE | 86 | Q8WTR7 | |
| TEGMDEAFAFRDDTS | 371 | O15069 |